KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEquity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Takeda Pharmaceutical (TAK) Shares Outstanding (Diluted Average) (2025 - 2026)

Takeda Pharmaceutical has reported Shares Outstanding (Diluted Average) over the past 2 years, most recently at $762.89 for Q1 2026.

  • For Q1 2026, Shares Outstanding (Diluted Average) rose 73.12% year-over-year to $762.89; the TTM value through Mar 2026 reached $762.89, up 73.12%, while the annual FY2026 figure was $794.79, 80.08% up from the prior year.
  • Shares Outstanding (Diluted Average) was $762.89 for Q1 2026 at Takeda Pharmaceutical, up from $440.67 in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $762.89 in Q1 2026 and bottomed at $440.67 in Q1 2025.